ADVFN - Advanced Financial Network.
HOME» NYSE » M » MRK Stock Price » MRK Stock News

Merck Share News

 Merck & Co., Stock Price
MRK Stock Price
 Merck & Co., Stock Chart
MRK Stock Chart
 Merck & Co., Stock News
MRK Stock News
 Merck & Co., Company Information
MRK Company Information
 Merck & Co., Stock Trades
MRK Stock Trades

Merck in Talks to Buy Indian Pharmaceutical Ingredients Maker Micro Labs - Report

Merck & Co. Inc. (MRK) is in talks to acquire Indian active pharmaceutical ingredients maker Micro Labs Ltd., the Financial Express reported Thursday, citing an unidentified person aware of the matter. The newspaper said Bangalore-based Micro Labs is a privately held company, founded and run by the Surana family. Micro Labs aims to achieve sales of about $1 billion by 2015, the report said, citing the company's website. A Merck India spokesperson declined to comment to the newspaper on any possible deal. Newspaper website: http://www.financialexpress.com Write to djn.in@dowjones.com

Stock News for Merck (MRK)
DateTimeHeadline
09/23/201609:41:00Merck's Keytruda Finds Fast Entry Into China Via Medical-Tourism...
09/23/201608:00:00Merck to Hold Third-Quarter 2016 Sales and Earnings Conference...
09/20/201608:30:00Merck to Host Investor Teleconference to Discuss ESMO 2016 Highlights
09/20/201603:03:00Business Watch -- WSJ
09/19/201611:49:00Sanofi Files Suit Against Merck, Claiming Patent Infringements...
09/19/201608:30:00Sanofi Files Suit Against Merck
09/19/201608:14:00Sanofi Files Suit Against Merck on Patent Infringements -Update
09/19/201602:08:00Sanofi Files U.S. Suit Against Merck on Patent Infringements
09/15/201610:03:00Merck, Pfizer Diabetes Therapy Meets Late-Stage Study Goals
09/13/201622:30:00Obama Administration Makes Last-Ditch Push for Trade Vote
09/13/201609:00:00Merck Publishes 2015/2016 Global Corporate Responsibility Report
09/13/201603:15:00Merck's Consumer Health Business Presents New Purpose to Help...
09/12/201608:00:00New Biosimilar can Offer an Effective and Lower Cost Treatment...
09/12/201608:00:00Un nouveau produit biosimilaire peut offrir une option thérapeutique...
09/09/201608:00:00Merck to Participate at the Morgan Stanley Global Healthcare...
09/08/201603:04:00Business Watch -- WSJ
09/07/201614:42:00FDA to Review Merck Drug as First-Line Treatment for Lung Cancer
09/07/201608:50:00FDA to Review Merck's Keytruda as First-Line Treatment for Lung...
09/07/201606:45:00FDA Accepts Supplemental Biologics License Application, Assigns...
09/02/201609:42:00U.S. Hot Stocks: Hot Stocks to Watch

Merck and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad